Medical Technology company Senseoonics Holdings (NYSE AMERICAN: SENS) shares are rallying premarket on Christmas eve after it said its fourth-quarter 2020 net revenue is expected to be approximately $3.5 million, above its prior expectation of $2.5 million.
The company’s strong performance was driven by sales in Europe and supported by Ascencia’s initial US sales. Seseonics and Ascencia formed a strategic partnership which saw Ascensia become the exclusive worldwide distributor of Senseonics’ Eversense CGM systems.
Senseonics said it expects its full-year 2021 revenue to be between $12 to $15 million.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Elsewhere the company said it received communication from the FDA that the marketing application review for its Eversense 180-day product, will be delayed by at least 60 days.
Finally, Senseonics has reached an agreement with Roche to facilitate the transition of distribution to Ascensia, as Roche sales conclude January 31, 2021, including final purchases, transition support activities, and resolution of other matters.
“In the first quarter of next year our top priority is executing an orderly commercial transition in Europe from Roche to Ascensia while maintaining uninterrupted patient and provider service,” commented Tim Goodnow, President and CEO of Senseonics.
Senseonics shares are trading 79% higher premarket at $1.16 following Wednesday’s close at $0.6470.
